These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 28577031

  • 1. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M.
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [Abstract] [Full Text] [Related]

  • 2. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE, Nuding MA.
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [Abstract] [Full Text] [Related]

  • 3. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
    Rony C, Aharoni S, Halevy A.
    Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604
    [Abstract] [Full Text] [Related]

  • 4. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G, Lafforgue MP, Lion-François L, Kemlin I, Rodriguez D, Castelnau P, Carneiro M, Meyer P, Rivier F, Barbarot S, Chaix Y, NF France network.
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [Abstract] [Full Text] [Related]

  • 5. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ, Gutmann DH.
    J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
    Cambiaso P, Galassi S, Palmiero M, Mastronuzzi A, Del Bufalo F, Capolino R, Cacchione A, Buonuomo PS, Gonfiantini MV, Bartuli A, Cappa M, Macchiaiolo M.
    Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895
    [Abstract] [Full Text] [Related]

  • 7. Optic pathway glioma in children: 10 years of experience in a single institution.
    Doganis D, Pourtsidis A, Tsakiris K, Baka M, Kouri A, Bouhoutsou D, Varvoutsi M, Servitzoglou M, Dana H, Kosmidis H.
    Pediatr Hematol Oncol; 2016 Mar; 33(2):102-8. PubMed ID: 27007263
    [Abstract] [Full Text] [Related]

  • 8. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

  • 9. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S, Flaherty M, Billson F, North K.
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [Abstract] [Full Text] [Related]

  • 10. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G.
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children].
    Florent C, Beylerian M, Mairot K, Dambricourt L, André N, David T, Girard N, Audic F, Denis D.
    J Fr Ophtalmol; 2022 Feb; 45(2):173-184. PubMed ID: 34972579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
    Avery RA, Mansoor A, Idrees R, Biggs E, Alsharid MA, Packer RJ, Linguraru MG.
    Neurology; 2016 Jun 14; 86(24):2264-70. PubMed ID: 27170570
    [Abstract] [Full Text] [Related]

  • 16. NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
    Azizi AA, Walker DA, Liu JF, Sehested A, Jaspan T, Pemp B, Simmons I, Ferner R, Grill J, Hargrave D, Driever PH, Evans DG, Opocher E, SIOPE NF1 OPG Nottingham, UK, Workshop 2014.
    Neuro Oncol; 2021 Jan 30; 23(1):100-111. PubMed ID: 32628746
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.